Intrinsic Value of S&P & Nasdaq Contact Us

Azenta, Inc. AZTA NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
46/100
3/7 Pass
SharesGrow Intrinsic Value
$69.76
+187.6%
Analyst Price Target
$43.00
+77.2%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Azenta, Inc. (AZTA) has a negative trailing P/E of -17.3, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 31.2 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -5.78%, forward earnings yield 3.20%. PEG 1.38.

Criteria proven by this page:

  • VALUE (60/100, Pass) — analyst target implies upside (+77.2%).
  • Forward P/E 31.2 — analysts expect a return to profitability with estimated EPS of $0.78 for FY2026.
  • PEG Ratio 1.38 — between 1.0–2.0 indicates moderate valuation relative to growth.
  • Trailing Earnings Yield -5.78% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 3.20% as earnings recover.
  • Analyst consensus target $43.00 (+77.2% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 46/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
46/100
SG Score
View full scorecard →
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
FUTURE
64/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
59/100
→ Income
GROWTH
30/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — AZTA

Valuation Multiples
P/E (TTM)-17.3
Forward P/E31.2
PEG Ratio1.38
Forward PEG1.38
P/B Ratio0.58
P/S Ratio1.69
EV/EBITDA14.3
Per Share Data
EPS (TTM)$-1.26
Forward EPS (Est.)$0.78
Book Value / Share$37.34
Revenue / Share$12.96
FCF / Share$0.67
Yields & Fair Value
Earnings Yield-5.78%
Forward Earnings Yield3.20%
Dividend Yield0.00%
SharesGrow IV$69.76 (+187.6%)
Analyst Target$43.00 (+77.2%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -13.4 0.02 1.68 1.66 2.96%
2017 33.7 -0.18 3.48 4.00 1.32%
2018 20.8 0.25 3.38 3.85 1.16%
2019 92.5 -1.01 2.34 3.41 1.08%
2020 52.5 0.10 2.80 8.76 0.87%
2021 68.6 -0.48 5.73 14.79 0.39%
2022 -7.5 0.12 0.95 5.78 0.23%
2023 -233.2 -5.00 1.31 5.00 -
2024 -15.6 -0.01 1.46 4.49 -
2025 -23.6 0.39 0.76 2.21 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-1.01 $560.32M $-69.48M -12.4%
2017 $0.89 $692.89M $62.61M 9%
2018 $1.64 $631.56M $116.58M 18.5%
2019 $0.14 $781.87M $9.89M 1.3%
2020 $0.88 $897.27M $64.85M 7.2%
2021 $-0.39 $513.7M $-28.87M -5.6%
2022 $-0.15 $555.5M $-11.29M -2%
2023 $-0.22 $665.07M $-14.26M -2.1%
2024 $-3.09 $656.32M $-164.17M -25%
2025 $-1.22 $593.82M $-55.76M -9.4%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.79 $0.77 – $0.80 $620.12M $613.39M – $626.84M 4
2027 $1.06 $1.04 – $1.08 $655.28M $647.63M – $662.92M 4
2028 $1.29 $1.05 – $1.47 $699.62M $696.49M – $702.76M 4
2029 $1.30 $1.27 – $1.33 $683.5M $673.34M – $694.81M 1
2030 $1.76 $1.73 – $1.80 $742.8M $731.76M – $755.09M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message